Top NewsUS News

French group Sanofi to buy U.S. firm Principia Biopharma for $3.7 billion

A lab technician dedicated to the vaccines formulation, wearing Personal Protective Equipment, prepares stainless steel tanks for manufacturing vaccines preparations before the syringe filling phase, at a French pharmaceutical company Sanofi’s world distribution centre in Val-de-Reuil.

Joel Saget | AFP via Getty Images

French health care company Sanofi has agreed to buy U.S. company Principia Biopharma for around $3.7 billion, the companies said on Monday, strengthening Sanofi’s presence in research and development (R&D) areas.

Sanofi said it would buy all of the outstanding shares of Principia for $100 per share in cash, representing an aggregate equity value of approximately $3.68 billion on a fully diluted basis.

“This acquisition advances our ongoing R&D transformation to accelerate development of the most promising medicines that will address significant patient needs,” said Sanofi chief executive Paul Hudson.

View Article Origin Here

Related Articles

Back to top button